The phosphorylation status of insulin-like growth factor-binding protein-1 in prepubertal obese children

European Journal of Endocrinology

Volumn 141, Issue 6, 1999, Pages 585-589

  Kamoda, Tomohiro ^a   Saitoh, Hisako ^a   Nakahara, Satoko ^b   Inudoh, Michiharu ^b   Hirano, Takeki ^c   Matsui, Akira ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Kensei General Hospital   (Japan)

^c Ibaraki Children's Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; OBESITY; PREPUBERTY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM;

EID: 0033375128     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410585     Document Type: Article

References (28)

1. Glass AR, Burmann KD, Dahms WT & Boehm TM. Endocrine function in human obesity. Metabolism 1981 30 89-104.
2. Meistas MT, Foster GV, Margolis S & Kowarski AA. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity. Metabolism 1982 31 1224-1228.
3. Jung RT, Campbell RG, James WPT & Callingham BA. Altered hypothalamic and sympathetic responses to hypoglycemia in familial obesity. Lancet 1982 1 1043-1046.
4. Kopelman PG & Noonan K. Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women. Clinical Endocrinology 1986 24 157-164.
5. Vignolo M, Naselli A, Di Battista E, Mostert M & Aicardi G. Growth and development in simple obesity. European Journal of Pediatrics 1988 147 242-244.
6. Vanderschueren-Lodeweyckx M. The effect of simple obesity on growth and growth hormone. Hormone Research 1993 40 23-30.
7. Frystyk J, Vestbo E, Skjærbæk C. Mogensen CE & Ørskov H. Free insulin-like growth factors in human obesity. Metabolism 1995 44 37-44.
8. Saitoh H, Kamoda T, Nakahara S, Hirano T & Nakamura N. Serum concentrations of insulin, insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-I and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children. Clinical Endocrinology 1998 48 487-492.
9. Lee PDK, Giudice LC, Conover, CA & Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proceedings of Society for Experimental Biology and Medicine 1997 216 319-357.
10. Jones JI, D'Ercole AJ, Camacho-Hubner C & Clemmons DR. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proceedings of the National Academy of Sciences ofthe USA 1991 88 7481-7485.
11. Jones JI, Busby WH, Wright G, Smith CE, Kimack NM & Clemmons DR. Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. Journal of Biological Chemistry 1993 268 1125-1131.
12. Westwood M, Gibson JM, Davies AJ, Young RJ & White A. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. Journal of Clinical Endocrinology and Metabolism 1994 79 1735-1741.
13. Koistinen R, Angervo M, Leinonen P, Hakala T & Seppälä M. Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clinica Chimica Acta 1993 215 189-199.
14. Khosravi MJ, Diamandi A & Mistry J. Immunoassay of insulin-like growth factor binding protein-1. Clinical Chemistry 1997 43 523-532.
15. Liu L, Brinkman A, Blot C & Harel L. IGFBP-1, an insulin-like growth factor binding protein is a cell growth inhibitor. Biochemical and Biophysical Research Communications 1991 174 673-679.
16. Elgin RG, Busby WH & Clemmons DR. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proceedings of the National Academy of Sciences of the USA 1987 84 5254-3258.
17. Busby WH, Klapper DG & Clemmons DR. Purification of a 31000-dalton insulin-like growth factor binding protein from amniotic fluid. Journal of Biological Chemistry 1988 263 14203-14210.
18. Frost RA & Tseng L. Insulin-like growth factor-binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. Journal of Biological Chemistry 1991 266 18082-18088.
19. Martina NA, Kim E, Chitkara U, Wathen NC, Chard T & Guidice LC. Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. Journal of Clinical Endocrinology and Metabolism 1997 82 1894-1898.
20. Iwashita M, Sakai K, Kudo Y & Takeda Y. Physiological significance of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) phosphoisoforms in fetal growth. Clinical Pediatric Endocrinology 1998 7 (Suppl 11) 31-37.
21. Argente J, Caballo N, Barrios V, Pozo J, Munoz MT, Chowen JA et al. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. Journal of Clinical Endocrinology and Metabolism 1997 82 2076-2083.
22. Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS et al. The metabolic syndrome and insulin-like growth factor regulation in adolescent obesity. Journal of Clinical Endocrinology and Metabolism 1998 83 1467-1471.
23. 3 Travers SH, Labarta JI, Gargosky SE, Rosenfeld RG, Jeffers BW & Eckel RH. Insulin-like growth factor binding protein-1 levels are strongly associated with insulin sensitivity and obesity in early pubertal children. Journal of Clinical Endocrinology and Metabolism 1998 83 1935-1939.
24. Slowinska-Srzednicka J, Zgliczynski W, Makowska A, Jeske W, Brzezinska A, Soszynski P et al. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity. Journal of Clinical Endocrinology and Metabolism 1992 74 1432-1455.
25. Cordido F, Casanueva FF, Vidai JI & Dieguez C. Study of insulin-like growth factor I in human obesity. Hormone Research 1991 36 187-191.
26. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK et al. Effects of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. International Journal of Obesity and Related Metabolic Disorders 1997 21 355-359.
27. Blat C, Villaudy J & Binoux M. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. Journal of Clinical Investigation 1994 93 2286-2290.
28. Westwood M, Gibson JM, Williams AC, Clayton PE, Hamberg O, Flyvbjerg A et al. Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status. Journal of Clinical Endocrinology and Metabolism 1995 80 3520-3527.